Dow has been named to an elite list of the top 50 innovation companies in the United States by CNBC.  The ranking evaluates companies based on their ability to increase revenue from R&D, using a unique formula which takes publicly available information to measures a company’s “Research Quotient” or the level of R&D productivity that links R&D spend to revenue growth and market value. Dow is the only chemical company to make CNBC’s list. This recognition comes on the heels of a record-breaking year in 2013 with more than 560 new patents granted.

“Our innovation pipeline is diverse and robust,” said A.N. Sreeram, Dow corporate vice president of R&D.  “Our customers value our partnership and consistently reward us with a seat at the design table, which drives our growth.  That’s the ultimately the recognition we seek, but it’s nice to have this external validation of the return on our research investment.”

Recently, Dow was honored with 5 products listed on the 2014 R&D 100 List which recognizes the top technology products of the year – the most awards given to any individual company.  Earlier this week, Dow’s Electronic Materials Business was recognized by ACS with the Heroes of Chemistry Award recognizing the vital role of industrial chemical scientists in improving human welfare through successful commercial innovations and products.

Notable recognitions such as these reflect Dow’s Human Element at Work. When Dow employees work together they develop advanced solutions based in science and improve the human condition.